Analytics
The Transformative Potential of the Galleri Test
In the field of oncology, early detection of cancer remains THE pivotal factor in improving patient outcomes. This challenge is being addressed by a groundbreaking innovation, the Galleri test. Developed by GRAIL, the Galleri test is a multi-cancer early detection blood test that analyzes cell-free DNA (cfDNA) to identify more than 50 types of cancer […]
Read more →